Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer
Guangfa Bao(Tongji Hospital), Xiaohua Zhu(Institute of Geographic Sciences and Natural Resources Research)
Cited by 26
Related Papers
18F-5-fluoro-aminosuberic acid PET/CT imaging of oxidative-stress features during the formation of DEN-induced rat hepatocellular carcinoma
|Theranostics|2024|3
Treatment of the prosthetic valve leakage
|Chinese Journal of Thoracic and Cardiovaescular Surgery|2016|0